HAL (France)open access
Checkpoint inhibitor effectiveness after corticosteroids and second-line immunosuppressants for immune-related adverse events in non-small-cell lung cancer
Checkpoint inhibitor, Corticosteroids, NSCLC, Immunosuppression, 0, 1, Immune-related adverse events, Toxicity
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 374506
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.